免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA PMA

具有算法分析的多分析测试系统,用于检测前列腺癌

PMA编号:P200048 · 2026-07-28

决定日期2026-07-28
PMA 编号P200048
产品代码QRF
设备分类第3类
医疗专科U
咨询委员会抱歉,您提供的信息不完整,无法进行翻译。请提供完整的医疗设备监管文本,以便我能够进行准确的翻译。

器械摘要

Multi-analyte test system with algorithmic analysis for detection of prostate cancer is the device name listed in this FDA 510(k) record. The listed applicant is Cleveland Diagnostics, Inc.. It received FDA 510(k) clearance on 2026-07-28. The device is classified under product code QRF. It was reviewed by the IM advisory panel.

常见问题

What is the Multi-analyte test system with algorithmic analysis for detection of prostate cancer?

Multi-analyte test system with algorithmic analysis for detection of prostate cancer is a medical device that received FDA 510(k) clearance on 2026-07-28. The listed applicant is Cleveland Diagnostics, Inc..

When did Multi-analyte test system with algorithmic analysis for detection of prostate cancer receive FDA 510(k) clearance?

The clearance date for Multi-analyte test system with algorithmic analysis for detection of prostate cancer can be found in the official FDA records.

谁是用于检测前列腺癌的多分析测试系统(具有算法分析)的列名申请人?

The FDA 510(k) record lists Cleveland Diagnostics, Inc. as the applicant. This does not by itself establish the device manufacturer.

什么是用于检测前列腺癌的多分析测试系统算法分析的FDA产品代码?

FDA产品代码为用于检测前列腺癌的多分析测试系统带算法分析的是QRF。

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑